Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05521789 · ClinicalTrials.gov registry record · Phase 4
Erector Spinae Block for Thoracic Surgery
A Phase 4 study of Thoracic Cancer and Thoracic Diseases, sponsored by George Washington University.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT05521789: Recruiting Phase 4 study of Thoracic Cancer and Thoracic Diseases, sponsored by George Washington University.
NCT05521789 is a Phase 4 study of Thoracic Cancer and Thoracic Diseases that is actively recruiting participants, run by George Washington University. The registered enrollment target is 70 participants, below the 344-participant average among 15 other Thoracic Cancer trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05521789, a Phase 4 study of Thoracic Cancer and Thoracic Diseases, is actively recruiting participants, sponsored by George Washington University.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to determine if erector spinae injections with bolus infusions with local anesthetic decrease postsurgical pain and opioid consumption in patients undergoing pulmonary resection surgery.
Primary Outcome
Study team members will record the patients' visual analogue pain score pain score on the scale of 0-10 (pain score 0-10 numerical rating) at 6 hours, as well as pain medications given. In addition, all patients will receive a Pain Diary with which to record the pain scores and medications received/taken. If a patient is discharged prior to the 24 hours, the patient will continue to fill out the Pain Diary at home up to the 24 hour mark. A phone call by a member of the study team within 72 hours
Conditions Studied
Interventions
- DRUG ESB Thoracic
Study Locations (1)
District of Columbia
- The George Washington University - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2022-07-22 |
| Est. Completion | 2027-07-21 |
| Phase | Phase 4 |
What NCT05521789 shows while recruiting
NCT05521789 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 344-participant average among 15 other Thoracic Cancer trials with a reported enrollment target (80% lower).
The record links to 5 conditions, with Thoracic Cancer appearing as the primary indexed condition, and to 1 intervention - of which ESB Thoracic is the first listed.
NCT05521789 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT05521789 about?
NCT05521789 is a clinical study titled "Erector Spinae Block for Thoracic Surgery". The aim of this study is to determine if erector spinae injections with bolus infusions with local anesthetic decrease postsurgical pain and opioid consumption in patients undergoing pulmonary resection surgery.
What is the current status of trial NCT05521789?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2022-07-22. Estimated completion is 2027-07-21.
What conditions does trial NCT05521789 study?
This clinical trial studies the following conditions: Thoracic Cancer, Thoracic Diseases, Thoracic Neoplasms, Pulmonary Neoplasm, Pulmonary Cancer.
What interventions are being tested in trial NCT05521789?
The interventions under investigation include: ESB Thoracic (DRUG).
Who is sponsoring clinical trial NCT05521789?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05521789 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thoracic Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05521789's enrollment target sits among peer trials
70 9th of 15 higher than 7 of 15 other Thoracic Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Thoracic Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
RECRUITING · NA
-
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
RECRUITING · NA
-
Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT
RECRUITING
-
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
RECRUITING · Phase 1
-
SURGE: Supporting UnderRepresented Minorities in Genomics-based Cancer Trial Enrollment (Intervention)
RECRUITING · NA
-
Patient-Generated Health Data Collection During Chemoradiotherapy for Lung Cancer
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI